Armed with 10 years of research and practice in preclinical and clinical assessment, we are amongst the very best international teams working in the field of activated transcutaneous transport.
Patented Innovative Technology:
La Mésothérapie Ultrasonore®, our patented ultrasound mesotherapy, which is based on sonophoresis, provokes an efficient and reversible reduction in the tissues' barrier defense function.
Principle:
The microcavitation of the surface layer, which temporarily diminishes the tissues' natural defensive barrier, for the first time enables the transport of molecules beyond what has previously been possible.
Assisted by a multidisciplinary network, made up of doctors, researchers and technicians, we now master:
The totality of our results has given rise to scientific publications.
Transderma Systems accompanies you in the development strategy of your products. The opportunities offered by our innovative technology can be seen on various levels:
Ultrasound Mesotherapy simplifies the creation of formulations by temporarily diminishing the biological barrier of said complex tissues.
Ultrasound mesotherapy is today a benchmark tool, indispensable for creating innovative formulations. Our technology guarantees an optimal bioavailability of the formulations allowing a rapid demonstration of their function in situ.
Ultrasound mesotherapy at last enables the transmembrane administration of actives on the market and of those in the process of being developed.
© 2010 Transderma Systems | Home | Legal considerations